| NCT ID | NCT03544489 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Heart Arrest |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2029-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2025-05-01 with a primary completion date of 2029-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will test an exercise intervention (E-ICD) following an implantable cardioverter defibrillator.
Eligibility Criteria
Inclusion Criteria: * ICD implantation for primary or secondary prevention of sudden cardiac arrest, -ability to read, speak and write English,- * access to a reliable phone for 6 months after study entry, * able to ambulate without assist devices for at least 5-10 minutes/day * greater than 18 years of age. Exclusion Criteria: * current diagnosis of serious mental disorder, * regular non-medical use of illicit drugs (opiates, cocaine, amphetamines, etc.), -unstable angina, myocardial infarction, ICD shock or heart surgery within previous 3 months * pregnancy * concurrent participation in an exercise program \> 5 days/week.
Contact & Investigator
Cynthia M Dougherty, ARNP, PhD
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT03544489 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03544489 currently recruiting?
Yes, NCT03544489 is actively recruiting participants. Contact the research team at cindyd@uw.edu for enrollment information.
Where is the NCT03544489 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT03544489 clinical trial?
NCT03544489 is sponsored by University of Washington. The principal investigator is Cynthia M Dougherty, ARNP, PhD at University of Washington. The trial plans to enroll 210 participants.